Nestmedic

Nestmedic Operating Cash Flow

The Operating Cash Flow of Nestmedic (NST.WA) as of Nov 17, 2026 is -7.27 M PLN. In the previous year, Operating Cash Flow was -4.31 M PLN — a change of 68.61% (lower).

Operating Cash Flow

-7.27 MPLN

YoY

68.61%

Last updated:

Operating Cash Flow of Nestmedic is 2025 -7.27 M PLN. Operating Cash Flow of Nestmedic was 2024 -4.31 M PLN. It decreases by 68.61% lower compared to the previous year.

The Nestmedic Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
-2.86 M PLN
Jan 1, 2019
-2.59 M PLN
Jan 1, 2020
-1.77 M PLN
Jan 1, 2021
-7.80 M PLN
Jan 1, 2022
-8.21 M PLN
Jan 1, 2023
-6.67 M PLN
Jan 1, 2024
-4.31 M PLN
Jan 1, 2025
-7.27 M PLN
The Nestmedic Operating Cash Flow history
YEAROperating Cash FlowYoY
-7.27 MPLN+68.61%
-4.31 MPLN-35.40%
-6.67 MPLN-18.79%
-8.21 MPLN+5.26%
-7.80 MPLN+341.43%
-1.77 MPLN-31.64%
-2.59 MPLN-9.60%
-2.86 MPLN-44.95%
-5.20 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nestmedic Stock analysis

What does Nestmedic do? Nestmedic SA generates revenue through the sale of its Pregnabit telemedicine CTG device, which includes the display device, fetal heart rate probe, wrist heart rate monitor, tocodynamometer probe, and fetal movement marker. The company targets healthcare providers and clinics that require home-based fetal monitoring solutions, enabling pregnant women to conduct CTG tests independently. Medical Telemonitoring Center (MTC) processes the wireless data from Pregnabit, providing medical analysis and opinions to users. Nestmedic SA's product is designed for direct consumer use in home settings with professional medical oversight. The Pregnabit solution is marketed to healthcare institutions seeking to offer remote fetal health monitoring services. By eliminating the need for in-person specialist visits, the device supports cost-effective maternal care. MTC serves as the central hub for data analysis, ensuring medical professionals can interpret results and deliver timely advice without direct patient interaction. Nestmedic SA focuses on the development and production of this integrated telemedicine system for fetal monitoring. Nestmedic SA's business model relies on selling the Pregnabit device and associated hardware to healthcare facilities. The wireless transmission of data to MTC allows for continuous medical supervision without requiring patients to visit clinics. The company's core offering combines hardware, software, and medical analysis services to provide a comprehensive solution for home-based fetal health monitoring. Nestmedic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nestmedic stock

Operating Cash Flow of Nestmedic is -7.27 M PLN in 2025.

Operating Cash Flow of Nestmedic changed from -4.31 M PLN to -7.27 M PLN, representing a 68.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Nestmedic since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Nestmedic historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Nestmedic

All Key Metrics — Nestmedic